METHODS AND COMPOSITIONS FOR PLANT PATHOGEN RESISTANCE IN PLANTS

    公开(公告)号:US20230257762A1

    公开(公告)日:2023-08-17

    申请号:US18089975

    申请日:2022-12-28

    Inventor: Nian WANG

    CPC classification number: C12N15/8281

    Abstract: The disclosure relates to a plant that is tolerant or resistant to species of Ca. Liberibacter. Specifically exemplified are citrus and solanaceous plants. Provided by the disclosure is a modified citrus or solanaceous plant that is resistant or tolerant to Sec-dependent effectors secreted by bacteria. Also provided by the disclosure are methods of modifying a plant genome plant to provide tolerance or resistance to species of Ca. Liberibacter. Still further provided by the disclosure are methods conferring a population of plants with tolerance or resistance to species of Ca. Liberibacter and screening that population for the plants that are tolerant or resistant to species of Ca. Liberibacter.

    AMINO ACID COMPOSITIONS AND USES THEREOF
    53.
    发明公开

    公开(公告)号:US20230255916A1

    公开(公告)日:2023-08-17

    申请号:US18167110

    申请日:2023-02-10

    CPC classification number: A61K31/198 A61K31/405

    Abstract: The present disclosure provides compositions and methods for promoting stem cell and/or progenitor cell proliferation and/or differentiation. The provided compositions may be useful in treating a disease or condition that is related to mucosal barrier function, e.g., wound healing, treating skin conditions (e.g., atopic dermatitis, psoriasis, bed sores, or condition related to the aging of skin), treating a lung disorders (e.g., asthma), a condition related to improving mucosal barrier function, and/or treating injury to GI mucosa in a subject in need thereof. The present disclosure also provides methods for promoting the proliferation and/or differentiation of stem cells and/or the progenitor cells in a subject in need of such treatment by administering a composition. The ability to stimulate the proliferation and/or differentiation of stem cells and/or the progenitor cells in vivo, ex vivo and/or in vitro provides tremendous benefit. The present disclosure can be used to increase stem cell populations in in vivo, ex vivo and/or in vitro. Stem cell transplantation provides treatments and/or cures of many disease states, degeneration and/or injury.

    SOFT TISSUE SURGICAL TASK TRAINER
    58.
    发明公开

    公开(公告)号:US20230169889A1

    公开(公告)日:2023-06-01

    申请号:US17919139

    申请日:2021-05-05

    CPC classification number: G09B23/30 A61L31/12

    Abstract: The disclosure relates to a simulated tissue useful as a surgical training aid, the simulated tissue including at least the following: (a) a skin layer, (b) a fat layer, (c) a muscle layer, (d) a first mesh, (e) an interstitial layer, (f) a second mesh, (g) a structural layer incorporating one or more anatomical components, and (h) a base layer. Methods for constructing the simulated tissue are also disclosed. The simulated tissues described herein can be used as a soft tissue surgical task trainer for numerous surgical procedures.

    GENE THERAPY FOR COCKAYNE SYNDROME
    59.
    发明公开

    公开(公告)号:US20230158173A1

    公开(公告)日:2023-05-25

    申请号:US17912690

    申请日:2021-03-19

    CPC classification number: A61K48/0066 A61P25/00 C12N9/16

    Abstract: Provided herein are methods of treating a subject with Cockayne Syndrome (CS) or a predisposition thereto. Also provided are methods of treating a subject with one or more mutations in an ERCC5 gene, an ERCC8 gene, an ERCC6 gene, or a combination thereof, methods of delaying the onset of Cockayne Syndrome (CS), or a symptom thereof, in a subject with one or more mutations in an ERCC5 gene, an ERCC8 gene, an ERCC6 gene, or a combination thereof, and methods of slowing, halting or reversing progression of Cockayne Syndrome (CS) in a subject. In exemplary embodiments, the method comprises administering to the subject a replication-incompetent Adeno-associated Vims (riAAV) comprising a nucleotide sequence encoding a Xeroderma Pigmentosum group G (XPG) protein, a Cockayne Syndrome type A (CSA) protein, or a Cockayne Syndrome type B (CSB) protein in an effective amount. Provided herein are related Adeno-associated Virus and cells comprising the same.

    COLLABORATIVE FEATURE ENSEMBLING ADAPTATION FOR DOMAIN ADAPTATION IN UNSUPERVISED OPTIC DISC AND CUP SEGMENTATION

    公开(公告)号:US20230141896A1

    公开(公告)日:2023-05-11

    申请号:US17915362

    申请日:2021-03-23

    Inventor: Peng Liu Ruogu Fang

    CPC classification number: A61B3/0025 A61B3/12 G06V10/82 G06V40/197

    Abstract: Embodiments of the present disclosure are directed to training a neural network for ocular cup (OC) or ocular disc (OD) detection. One such method comprises initiating training of a first network to learn detection of OC/OD regions within a labeled source sample from a source domain; sharing training weights of the first network with a second network; initiating training of the second network to learn detection of OC/OD regions within an unlabeled sample from a target domain; transferring average training weights of the second network to a third network; initiating training of the third network to learn detection of OC/OD regions within an unlabeled sample from the target domain; computing a mean square error loss between the third network and the second network for a same target sample; and adjusting training weights of the second network based on the mean square error loss computation.

Patent Agency Ranking